SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-041504
Filing Date
2024-02-21
Accepted
2024-02-21 16:29:08
Documents
17
Period of Report
2024-02-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d774502d8k.htm   iXBRL 8-K 28551
2 EX-10.1 d774502dex101.htm EX-10.1 41418
3 EX-99.1 d774502dex991.htm EX-99.1 12259
7 GRAPHIC g774502g11t14.jpg GRAPHIC 2762
  Complete submission text file 0001193125-24-041504.txt   236257

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ikna-20240220.xsd EX-101.SCH 2868
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikna-20240220_lab.xml EX-101.LAB 19500
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikna-20240220_pre.xml EX-101.PRE 12168
18 EXTRACTED XBRL INSTANCE DOCUMENT d774502d8k_htm.xml XML 3909
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 24660044
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)